BioSight
Companies
Protagonist Therapeutics, Inc logo

PTGX

NASDAQNEWARK, CA
Protagonist Therapeutics, Inc

Protagonist Therapeutics develops drug candidates using peptide and small molecule modalities targeting gastrointestinal and inflammatory disorders. The pipeline is in clinical development stage, with programs advancing through non-clinical studies and clinical trials aimed at eventual regulatory approval and commercialization. The excerpt provided does not contain sufficient detail about specific product candidates or their development phases to offer more precise information.

Price history not yet available for PTGX.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar